» Articles » PMID: 31371720

Obsessive-compulsive Disorder

Overview
Specialty General Medicine
Date 2019 Aug 3
PMID 31371720
Citations 227
Authors
Affiliations
Soon will be listed here.
Abstract

Obsessive-compulsive disorder (OCD) is a highly prevalent and chronic condition that is associated with substantial global disability. OCD is the key example of the 'obsessive-compulsive and related disorders', a group of conditions which are now classified together in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, and the International Classification of Diseases, 11th Revision, and which are often underdiagnosed and undertreated. In addition, OCD is an important example of a neuropsychiatric disorder in which rigorous research on phenomenology, psychobiology, pharmacotherapy and psychotherapy has contributed to better recognition, assessment and outcomes. Although OCD is a relatively homogenous disorder with similar symptom dimensions globally, individualized assessment of symptoms, the degree of insight, and the extent of comorbidity is needed. Several neurobiological mechanisms underlying OCD have been identified, including specific brain circuits that underpin OCD. In addition, laboratory models have demonstrated how cellular and molecular dysfunction underpins repetitive stereotyped behaviours, and the genetic architecture of OCD is increasingly understood. Effective treatments for OCD include serotonin reuptake inhibitors and cognitive-behavioural therapy, and neurosurgery for those with intractable symptoms. Integration of global mental health and translational neuroscience approaches could further advance knowledge on OCD and improve clinical outcomes.

Citing Articles

Clinical Characteristics of Cognitive Subgroups of Obsessive Compulsive Disorder.

Misir E, Tukel R, Akdede B, Bora E Brain Behav. 2025; 15(3):e70375.

PMID: 40079623 PMC: 11904946. DOI: 10.1002/brb3.70375.


Abnormal static and dynamic functional connectivity of striatal subregions in patients with obsessive-compulsive disorder.

Shi W, Tian Y, Yang H, Guo H, Wen B, Liu Z Front Psychiatry. 2025; 16:1529983.

PMID: 40060744 PMC: 11885261. DOI: 10.3389/fpsyt.2025.1529983.


How the brain decides when to stick at it, give up or try something new.

Nature. 2025; .

PMID: 40045125 DOI: 10.1038/d41586-025-00631-0.


Bibliometric analysis of OCD prevalence in youth populations of developing countries.

Blaney J, Konda S, Ganti L Glob Ment Health (Camb). 2025; 12:e21.

PMID: 40028389 PMC: 11867827. DOI: 10.1017/gmh.2025.12.


A systematic review of structural neuroimaging markers of psychotherapeutic and pharmacological treatment for obsessive-compulsive disorder.

Moreau A, Hansen I, Bogdan R Front Psychiatry. 2025; 15:1432253.

PMID: 40018086 PMC: 11865061. DOI: 10.3389/fpsyt.2024.1432253.


References
1.
Paydary K, Akamaloo A, Ahmadipour A, Pishgar F, Emamzadehfard S, Akhondzadeh S . N-acetylcysteine augmentation therapy for moderate-to-severe obsessive-compulsive disorder: randomized, double-blind, placebo-controlled trial. J Clin Pharm Ther. 2016; 41(2):214-9. DOI: 10.1111/jcpt.12370. View

2.
Pujol J, Soriano-Mas C, Alonso P, Cardoner N, Menchon J, Deus J . Mapping structural brain alterations in obsessive-compulsive disorder. Arch Gen Psychiatry. 2004; 61(7):720-30. DOI: 10.1001/archpsyc.61.7.720. View

3.
Zhou D, Wang W, Wang G, Li D, Kuang L . An updated meta-analysis: Short-term therapeutic effects of repeated transcranial magnetic stimulation in treating obsessive-compulsive disorder. J Affect Disord. 2017; 215:187-196. DOI: 10.1016/j.jad.2017.03.033. View

4.
Fan S, Cath D, van der Werf Y, de Wit S, Veltman D, van den Heuvel O . Trans-diagnostic comparison of response inhibition in Tourette's disorder and obsessive-compulsive disorder. World J Biol Psychiatry. 2017; 19(7):527-537. DOI: 10.1080/15622975.2017.1347711. View

5.
Khanna S . Obsessive-compulsive disorder: is there a frontal lobe dysfunction?. Biol Psychiatry. 1988; 24(5):602-13. DOI: 10.1016/0006-3223(88)90171-0. View